Remdesivir Market Growth Outlook: Protocolized Hospital Use, Preparedness Planning, and Competitive Antiviral Landscape (2026–2034)
The remdesivir market is a focused antiviral therapeutics segment shaped by the long tail of COVID-19 clinical need and the shift from pandemic surge volumes to targeted use in high-risk patients. Remdesivir is an intravenous direct-acting antiviral used in hospitalized settings and, in shorter courses, for select non-hospitalized patients when early treatment is intended to reduce progression...
0 Commentaires 0 Parts 47 Vue